We are live on ! Find out more
KA

Kozak & Associates Portfolio holdings

AUM $576M
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+14.34%
1 Year Est. Return
+23.37%
3 Year Est. Return
+97.43%
5 Year Est. Return
+117.62%
10 Year Est. Return
AUM
$372M
AUM Growth
+$56.5M
Cap. Flow
+$12.6M
Cap. Flow %
3.4%
Top 10 Hldgs %
73.71%
Holding
440
New
67
Increased
163
Reduced
75
Closed
44

Sector Composition

Rank Sector Weight
1 Technology 19.2%
2 Financials 4.87%
3 Consumer Discretionary 4.75%
4 Consumer Staples 4.03%
5 Industrials 3.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEI icon
251
iShares 3-7 Year Treasury Bond ETF
IEI
$17.8B
$8.01K ﹤0.01%
70
-196
-74% -$22.7K
ACGL icon
252
Arch Capital
ACGL
$33.6B
$7.81K ﹤0.01%
+79
New +$6.68K
VEA icon
253
Vanguard FTSE Developed Markets ETF
VEA
$236B
$7.79K ﹤0.01%
+153
New +$7.39K
EQC.PRD
254
DELISTED
Equity Commonwealth 6 1/2% Series D Cumulative Convertible Preferred Shares
EQC.PRD
$7.71K ﹤0.01%
310
+10
+3% +$252
UNM icon
255
Unum
UNM
$14.3B
$7.12K ﹤0.01%
+135
New +$6.58K
SCHH icon
256
Schwab US REIT ETF
SCHH
$11.4B
$6.89K ﹤0.01%
+344
New +$6.9K
SBS icon
257
Sabesp
SBS
$18.7B
$6.63K ﹤0.01%
+2,202
New +$6.72K
FLIA icon
258
Franklin International Aggregate Bond ETF
FLIA
$768M
$6.62K ﹤0.01%
+328
New +$6.6K
BLDR icon
259
Builders FirstSource
BLDR
$8.04B
$6.62K ﹤0.01%
+40
New +$7.39K
IWY icon
260
iShares Russell Top 200 Growth ETF
IWY
$16.6B
$6.59K ﹤0.01%
+33
New +$6.17K
FPX icon
261
First Trust US Equity Opportunities ETF
FPX
$1.51B
$6.51K ﹤0.01%
63
HCA icon
262
HCA Healthcare
HCA
$89.5B
$6.5K ﹤0.01%
20
SCHX icon
263
Schwab US Large- Cap ETF
SCHX
$74.5B
$6.46K ﹤0.01%
309
GIS icon
264
General Mills
GIS
$19.7B
$6.28K ﹤0.01%
88
+2
+2% +$130
CION icon
265
CION Investment
CION
$374M
$6.21K ﹤0.01%
499
+15
+3% +$165
PKW icon
266
Invesco BuyBack Achievers ETF
PKW
$1.76B
$6.18K ﹤0.01%
59
IWP icon
267
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
$6.04K ﹤0.01%
54
+50
+1,250% +$5.41K
VRTX icon
268
Vertex Pharmaceuticals
VRTX
$126B
$5.73K ﹤0.01%
13
UTHR icon
269
United Therapeutics
UTHR
$23.1B
$5.72K ﹤0.01%
+21
New +$4.74K
SLYG icon
270
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.2B
$5.62K ﹤0.01%
64
VIG icon
271
Vanguard Dividend Appreciation ETF
VIG
$114B
$5.59K ﹤0.01%
30
MU icon
272
Micron Technology
MU
$991B
$5.43K ﹤0.01%
42
-31
-42% -$2.81K
MRO
273
DELISTED
Marathon Oil Corporation
MRO
$5.25K ﹤0.01%
201
+1
+0.5% +$24
SH icon
274
ProShares Short S&P500
SH
$897M
$5.15K ﹤0.01%
109
+2
+2% +$100
BMY icon
275
Bristol-Myers Squibb
BMY
$132B
$5K ﹤0.01%
113
+3
+3% +$153

Similar funds

Kozak & Associates's Q1 2024 Portfolio in Review

As of Q1 2024, Kozak & Associates held 440 positions worth $372M, up 18% from $315M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Kozak & Associates deployed $12.6M of net new capital in Q1 2024, opening 67 new positions and adding to 163 existing holdings. Its largest new stake was GE Vernova: 838 shares worth $139K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $692K trimmed.

  • Kozak & Associates's largest Q1 2024 buy was GE Vernova: 838 shares worth $139K.
  • Kozak & Associates added most to Invesco S&P 500 Revenue ETF in Q1 2024, an estimated $4.13M increase.
  • Kozak & Associates's biggest Q1 2024 reduction was Tesla, cutting an estimated $692K.
  • Kozak & Associates fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q1 2024, selling an estimated $67K.
  • Kozak & Associates's ten largest holdings make up 74% of its $372M portfolio in Q1 2024.
  • Kozak & Associates opened 67 new positions and closed 44 in Q1 2024.
  • Kozak & Associates's portfolio value rose 18% quarter-over-quarter to $372M.

Based on Kozak & Associates's 13F filing for Q1 2024, filed 17 May 2024.